<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>PharmAthene Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>PharmAthene Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/PharmAthene_Inc-3718774</link>
<lastBuildDate>Monday, October 13, 2008 2:15:28 AM</lastBuildDate>
<alacra:xlsid>3718774</alacra:xlsid>
<alacra:company>PharmAthene Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-28468203</link><guid isPermaLink="false">newstex/PRN-0005-28468203</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> ANNAPOLIS, Md., Sep. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- PharmAthene, Inc. (Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it has...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11001000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11001007</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016005</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016019</newstex:cat><pubDate>9/30/2008 5:20:47 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18016000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18013000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-28468203</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">PANACEA BIOTEC LTD</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">PHARMATHENE INC</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">DAVID P WRIGHT</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">PCEBF</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">PIP</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1975341</link><guid isPermaLink="false">ccbn/T1975341</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good afternoon, ladies and gentlemen. And welcome once again to the #### Global Life Science conference. My name is [Clay Cole], and I'd just like to welcome you and say thank you for coming. This afternoon, we have the pleasure to hear David Wright, President and CEO of PharmAthene, give us a brief presentation. I'd like to remind you that after the presentation, there will be a breakout in the Alvin Room, which is located downstairs. Thank you very much. David? ...

</description><pubDate>9/29/2008 8:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Pharmathene</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Pharmathene at UBS Global Life Sciences Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">PIP</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">1:30pm ET</ccbn:time><title>Pharmathene at UBS Global Life Sciences Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1975341</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1893866</link><guid isPermaLink="false">ccbn/T1893866</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen, and welcome to the Second Quarter #### PharmAthene Earnings Conference Call. My name is Ahmed and I will be your coordinator for today. At this time all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of today's conference. (OPERATOR INSTRUCTIONS) I would now like to turn the presentation over to your host for today's conference, Stacey, Director of Corporate Communications. ...

</description><pubDate>8/14/2008 10:05:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Pharmathene</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Pharmathene Q2 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">PIP</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:30pm ET</ccbn:time><title>Pharmathene Q2 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1893866</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/MCOM-0004-27376736</link><guid isPermaLink="false">newstex/MCOM-0004-27376736</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Aug. ##, #### (M# Communications Ltd. delivered by Newstex) -- PharmAthene Inc (Amex: PIP), a bio-defence company, disclosed on ## August its financial and operational results for the second quarter and six months ended ## June ####....</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016047</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><pubDate>8/13/2008 10:21:58 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">M2 EquityBites</newstex:Publication><title>PharmAthene Inc discloses Q2 2008 financial and operational results</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">MCOM-0004-27376736</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">PHARMATHENE INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">PIP</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-27354586</link><guid isPermaLink="false">newstex/PRN-0005-27354586</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> ANNAPOLIS, Md., Aug. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- PharmAthene, Inc. (Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07005000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">16000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">16001000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016013</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11001000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">11001007</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">03000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">03002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">03002004</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02003004</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02001000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02001008</newstex:cat><pubDate>8/12/2008 5:18:57 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18015000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18016000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>PharmAthene Reports Second Quarter 2008 Financial and Operational Results</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-27354586</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">PHARMATHENE INC</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">DAVID P WRIGHT</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">PIP</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1843929</link><guid isPermaLink="false">ccbn/T1843929</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen and welcome to the First Quarter #### PharmAthene Earnings Conference Call. My name is Katy and I'll be your coordinator for today. At this time all participants are in a listen-only mode. We will be conducting a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) I would now like to turn the call over to your host for today, Ms. Stacey Jurchison. Ma'am, you may proceed. ...

</description><pubDate>5/14/2008 3:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Pharmathene</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 Pharmathene Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">PIP</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:30pm ET</ccbn:time><title>Q1 2008 Pharmathene Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1843929</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1805388</link><guid isPermaLink="false">ccbn/T1805388</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen, and welcome to the fourth quarter #### PharmAthene earnings conference call. (OPERATOR INSTRUCTIONS) I would now like to turn the presentation over to your host for today, Ms. Stacey Jurchison. Please proceed. ...

</description><pubDate>3/31/2008 8:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Pharmathene</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 Pharmathene Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">PIP</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:30pm ET</ccbn:time><title>Q4 2007 Pharmathene Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1805388</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1793630</link><guid isPermaLink="false">ccbn/T1793630</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day ladies and gentlemen and welcome to the PharmAthene-Avecia acquisition conference call. My name is Denise and I will be your coordinator for today's conference. At this time, all participants are in listen-only mode. We will be conducting a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call, Ms. Stacey Jurchison, Director of Corporate Communications. Please proceed, ma'am. ...

</description><pubDate>3/21/2008 9:05:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Pharmathene</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 Pharmathene Earnings &amp; Discussion of Avecia Acquisition Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">PIP</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:30pm ET</ccbn:time><title>Q4 2007 Pharmathene Earnings &amp; Discussion of Avecia Acquisition Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1793630</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item></channel></rss>